FDA Issues Work Plan For Independent Assessment Of Pre-market Review Process
This article was originally published in The Gray Sheet
Executive Summary
The assessment, called for by industry during the device user fee reauthorization, will be conducted by an independent consulting firm. The goal is to identify efficiencies in the device review process.
You may also be interested in...
Independent Assessment Of CDRH Calls For Staff Training, Review Process Improvements
The priority recommendations from Booz Allen Hamilton, the independent contractor selected to assess CDRH’s review process for device submissions, include improving staff training on information technology systems and adopting a holistic, multipronged approach to standardize reviews.
Shuren To Lawmakers: Sequestration Is “Killing Us”
CDRH Director Jeffrey Shuren fears the center won’t be able to meet commitments to hire new employees for FY 2014 if the sequester continues, he told members of the House Energy & Commerce Health Subcommittee last week.
MDMA Will Focus On FDA Performance, Device Tax Repeal In 2013
The Medical Device Manufacturers Association discusses its top priorities for the new year.